SCHEMBL20219471

SCHEMBL20219471

CCCCNc1nc(C)ncc1OCCOc1ccnc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.44
▸ S1PR2 O95136 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ ACP1 P24666 1/20 0.43
▸ HTR1A P08908 2/20 0.42
▸ ADRA1D P25100 2/20 0.42
▸ ADRA1A P35348 2/20 0.42
▸ ADRA1B P35368 2/20 0.42
▸ CASP6 P55212 1/20 0.41
▸ UTS2R Q9UKP6 4/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ GBA1 P04062 1/20 0.39
▸ TLR8 Q9NR97 1/20 0.39
▸ TLR7 Q9NYK1 1/20 0.39
▸ CYP1A2 P05177 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23472301 0.88 NPSR1 (0.43) NPSR1S1PR2LMNASMN1; SMN2ACP1
SCHEMBL15470014 0.88 TLR8 (0.48) NPSR1S1PR2LMNASMN1; SMN2ACP1
SCHEMBL20219347 0.85 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BTLR8
SCHEMBL23472425 0.85 CASP6 (0.41) NPSR1S1PR2LMNASMN1; SMN2ACP1
SCHEMBL20219552 0.81 TLR7 (0.36) NPSR1KDM4EL3MBTL1CYP3A4TLR8
SCHEMBL23472288 0.78 TLR8 (0.38) NPSR1S1PR2LMNASMN1; SMN2KDM4E
SCHEMBL20219572 0.78 CYP2D6 (0.43) LMNASMN1; SMN2CYP2D6KDM4ECYP3A4
SCHEMBL20219543 0.78 TLR8 (0.47) LMNASMN1; SMN2CASP6CYP2D6L3MBTL1
SCHEMBL20219324 0.78 CHRNB2 (0.47) SMN1; SMN2CYP2D6CYP3A4GBA1TLR8
SCHEMBL20219430 0.77 TLR7 (0.42) NPSR1CYP2D6KDM4EL3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3590928-B1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) 2021-06-09 — — EP disclosed
EP-3330257-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS Janssen Sciences Ireland UC (IE) 2018-06-06 — — EP disclosed
Send feedback